Upstream Process Development Challenges in Biosimilar mAb Production

Monoclonal antibodies, or mAbs, have been the most popular type of biological medicine on the market for more than 30 years. The demand for mAbs is on the rise, and increased production will be required to meet patient needs in the future. Most monoclonal antibodies (mAbs) are used to treat cancer a...